Posted on Thursday, January 21, 2016 by Paul Etzler, CPA, CGMA, GACP
Our “best guesses” continue to be refined through analytics and the power of data. If we apply the recent history of life science organizations in the U.S. to 2016 manufacturing, R&D, distribution and financial models, we can establish a baseline for what to expect in 2016.
Posted on Thursday, January 21, 2016 by Marilea Campomizzi, CPA
Big things are continuing to develop with equity crowdfunding. On October 30, 2015, the Securities Exchange Commission (SEC) issued final rules under Title III of the JOBS Act of 2012 that will allow equity crowdfunding through online portals.
Posted on Friday, October 9, 2015 by Business Advisory Skoda Minotti
BioOhio, Ohio’s bioscience membership organization, is excited to host several events in the remainder of 2015.
Posted on Thursday, October 8, 2015 by Paul Etzler, CPA, CGMA, GACP
As an early stage venture – or an existing company with new technologies – it is vitally important to prepare a financial budget, then use it each month (or week, or even day) to ensure you are meeting your expectations.
Posted on Tuesday, October 6, 2015 by Marilea Campomizzi, CPA
Crowdfunding is the practice of funding a project or venture by raising many small amounts of money from a large number of people. This popular method of raising money can create a lot of questions from an accounting and tax standpoint.
Posted on Friday, June 27, 2014 by Marilea Campomizzi, CPA
In one of my earlier blogs, I referenced specific accounting standards required for Development Stage Entities (DSEs). The Financial Accounting Standards Board (FASB) recently issued Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915), which eliminated all unique reporting requirements for these type of entities as well as removed an exception that was […]
Posted on Wednesday, June 11, 2014 by Marilea Campomizzi, CPA
Skoda Minotti Life Sciences and Innovation group, led by Marilea Campomizzi, CPA and Paul Etzler, CPA, CGMA, GACR, recently sponsored BioOhio Unplugged: CEOs & Leadership Series in Columbus, Ohio. The event featured G. Steven Burrill, who presented on his 28th Annual Report “Transforming Healthcare,” along with a recognized panel of life science industry CEOs and […]
Posted on Tuesday, February 25, 2014 by Paul Etzler, CPA, CGMA, GACP
With Northeast Ohio strengthening its foundation in the bioscience space, we’ve kept a close eye on patent law developments that may impact or impede a company's road to progress. In a recent article in Crain’s Cleveland Business, Susan M. Hopkins stated: the “U.S. Supreme Court answered a longstanding question in intellectual property law: Can a […]
Posted on Saturday, December 14, 2013 by Business Advisory Skoda Minotti
The following article is brought to you by our colleagues at the law firm of Hahn Loeser & Parks. Companies accused of patent infringement now have a more cost effective method to contest the validity of asserted patents as compared to traditional litigation. The America Invents Act introduced Inter Partes Review (IPR)–a new procedure at […]
Posted on Friday, December 6, 2013 by Marilea Campomizzi, CPA
Under current accounting standards, startup companies that are devoting substantially all of their efforts to creating a new business may be considered Development Stage Entities (DSE) if either 1) the principal operations haven’t commenced yet OR 2) principal operations have commenced, but there has been no significant revenues generated. Once identified as such, DSEs have […]